Contents
Summary
3-Fluoroethamphetamine (3-FEA) is a stimulant categorized within the amphetamine class. It is a releasing agent for the monoamine neurotransmitters, including norepinephrine, dopamine, and serotonin.
Compared to the non-substituted ethylamphetamine, 3-fluoroethamphetamine exhibits reduced potency in releasing noradrenaline. However, it demonstrates greater efficacy in releasing both dopamine and serotonin. Interestingly, in animal studies comparing various 3-substituted methamphetamine derivatives, 3-FEA displayed the most pronounced reinforcing effects, even though it wasn’t the most potent dopamine releaser among them.
| Identifiers | |
|---|---|
| IUPAC name | |
| CAS Number | 54982-43-3 |
|---|---|
| PubChem CID | 57458869 |
| ChemSpider | 27050449 |
| UNII | 7ZY9F4B6GT |
| Chemical and physical data | |
| Formula | C11H16FN |
| Molar mass | 181.254 g·mol−1 |
FAQ
1. What is 3-Fluoroethamphetamine (3-FEA)?
3-Fluoroethamphetamine (3-FEA) is a stimulant drug belonging to the amphetamine class. It functions as a releasing agent for certain neurotransmitters in the brain, including norepinephrine, dopamine, and serotonin.
2. How does 3-FEA work?
3-FEA primarily releases norepinephrine, dopamine, and serotonin in the brain. This leads to increased stimulation and mood enhancement.
3. What are the effects of 3-FEA?
The effects of 3-FEA may include increased energy, alertness, and euphoria. Users might also experience improved focus and sociability. However, it’s important to note that individual responses can vary.
4. Is 3-FEA legal?
The legal status of 3-FEA varies by country and jurisdiction. In many places, it falls under controlled substance regulations, making its possession, sale, or use illegal without proper authorization.
5. Are there health risks associated with 3-FEA use?
The long-term health risks of 3-FEA are not well understood, as it is a relatively new substance. However, as a stimulant, it may carry risks such as increased heart rate, blood pressure, and potential for addiction or psychological dependence.
6. Is 3-FEA addictive?
Like many stimulant drugs, 3-FEA has the potential for psychological dependence or addiction. Regular and excessive use can lead to cravings and withdrawal symptoms.
7. How is 3-FEA typically consumed?
3-FEA is commonly taken orally in the form of a pill or capsule. Users may also insufflate (snort) it, although this method can be harsh on the nasal passages.
8. Can 3-FEA be used safely?
Due to its limited research and potential health risks, 3-FEA is not recommended. The safest choice is to avoid its use altogether.
References
- Tessel RE, Woods JH (1974): In a study published in the “Pharmacologist” journal in 1974, researchers explored the structural relationship between meta-substituted N-ethylamphetamines and their self-administration in rhesus monkeys.
- Tessel RE, Woods JH, Counsell RE, Lu (February 1975): In a follow-up study published in “The Journal of Pharmacology and Experimental Therapeutics” in February 1975, scientists investigated the structure-activity relationships between meta-substituted N-ethylamphetamines and their impact on locomotor activity in mice.
- Tessel RE, Rutledge CO (May 1976): A study published in May 1976 in “The Journal of Pharmacology and Experimental Therapeutics” delved into the specificity of the release of biogenic amines from isolated rat brain tissue. The focus was on how it varies as a function of the meta substituent of N-ethylamphetamine derivatives.
- Tessel RE, Woods JH (May 1978): In May 1978, researchers continued their investigation, this time exploring meta-substituted N-ethylamphetamine self-injection responding in rhesus monkeys and establishing structure-activity relationships. This study was documented in “The Journal of Pharmacology and Experimental Therapeutics.”